CoChat
Sign Up
Cited by 107Fungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatmentAntifungal resistance and susceptibility

Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994–1997: incidence, risk factors, and prevention

Woods, Christopher W., McRill, Cheryl, Plikaytis, Brian D., Rosenstein, Nancy E., Mosley, David, Boyd, Denise, England, Bob, Perkins, Bradley A. +2 more·2000·The Journal of Infectious Diseases
DOI 10.1086/315401
Open this paper in CoChat — free account

Abstract

From 1 January 1995 through 31 June 1997, 153 cases of coccidioidomycosis in human immunodeficiency virus (HIV)-infected persons were identified in Arizona (incidence, 41/1000 persons living with AIDS). A case-control study was conducted to evaluate risk factors for coccidioidomycosis in HIV-infected persons. A case was defined as laboratory-confirmed, incident coccidioidomycosis in a person infected with HIV for > or =3 months, and each case patient had 3 control patients matched by county, age group, sex, HIV/AIDS status, and CD4 lymphocyte count. Multivariable analysis identified black race and a history of oropharyngeal or esophageal candidiasis to be associated with increased risk of coccidioidomycosis; protease inhibitor therapy was associated with a reduced risk. In persons with previous history of oropharyngeal or esophageal candidiasis, having received an azole drug was associated with a reduced risk (odds ratio, 0.4; 95% confidence interval, 0.2-0.9; P=.04). Physicians may need to consider azole chemoprophylaxis for HIV-infected persons who live in areas of endemicity, have CD4 cell counts <200/microL, are black, or have a history of thrush.

Integrity signals

Registry

Crossref · 10.1086/315401

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among immunocompromised patients, the risk of symptomatic coccidioidomycosis is higher among black or African American individuals with HIV infection compared to white individuals.

    “Among the immunocompromised patients, the risk of symptomatic coccidioidomycosis rates shown to be higher among black or African American individuals with HIV infection compared to white individuals [157]”

    From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [157]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Woods, C. W., McRill, C., Plikaytis, B. D., Rosenstein, N. E., Mosley, D., Boyd, D., England, B., Perkins, B. A., Ampel, N. M., & Hajjeh, R. A.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Arizona Department of Health Services (US)
  • University of Arizona (US)
Corresponding author
Hajjeh, Rana A.
ORCID
Venue
The Journal of Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
2000-04
Volume
181
Issue
4
Pages
1428-1434
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
DOI
10.1086/315401
OpenAlex
W2110678105
Cited by
107
References
32
Citations by year
2024: 2 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 8 · 2015: 5 · 2014: 5 · 2013: 6 · 2012: 5
FWCI
3.42
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Arizona Department of Health Services
  • Wake Forest School of Medicine
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
coccidioidomycosis, HIV infection, AIDS, incidence, risk factors, oropharyngeal candidiasis, esophageal candidiasis, protease inhibitors, azole antifungals, chemoprophylaxis, Black race, CD4 count, Arizona
MeSH terms
Adult, Arizona, Black or African American, Candidiasis, Oral, Coccidioidomycosis, Esophageal Diseases, Female, Humans, Male, Middle Aged, Oropharynx, Retrospective Studies, Risk Factors, Socioeconomic Factors, Incidence, Multivariate Analysis, Case-Control Studies, Databases, Factual, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Black People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review